1. Home
  2. RGR vs ORGO Comparison

RGR vs ORGO Comparison

Compare RGR & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGR
  • ORGO
  • Stock Information
  • Founded
  • RGR 1949
  • ORGO 1985
  • Country
  • RGR United States
  • ORGO United States
  • Employees
  • RGR N/A
  • ORGO N/A
  • Industry
  • RGR Ordnance And Accessories
  • ORGO Biotechnology: Pharmaceutical Preparations
  • Sector
  • RGR Industrials
  • ORGO Health Care
  • Exchange
  • RGR Nasdaq
  • ORGO Nasdaq
  • Market Cap
  • RGR 627.3M
  • ORGO 665.8M
  • IPO Year
  • RGR N/A
  • ORGO N/A
  • Fundamental
  • Price
  • RGR $39.43
  • ORGO $4.28
  • Analyst Decision
  • RGR
  • ORGO Buy
  • Analyst Count
  • RGR 0
  • ORGO 2
  • Target Price
  • RGR N/A
  • ORGO $5.50
  • AVG Volume (30 Days)
  • RGR 134.5K
  • ORGO 1.3M
  • Earning Date
  • RGR 05-06-2025
  • ORGO 05-08-2025
  • Dividend Yield
  • RGR 1.78%
  • ORGO N/A
  • EPS Growth
  • RGR N/A
  • ORGO N/A
  • EPS
  • RGR 1.77
  • ORGO N/A
  • Revenue
  • RGR $535,643,000.00
  • ORGO $482,043,000.00
  • Revenue This Year
  • RGR $4.74
  • ORGO N/A
  • Revenue Next Year
  • RGR N/A
  • ORGO $7.62
  • P/E Ratio
  • RGR $22.20
  • ORGO N/A
  • Revenue Growth
  • RGR N/A
  • ORGO 11.29
  • 52 Week Low
  • RGR $34.11
  • ORGO $2.17
  • 52 Week High
  • RGR $48.20
  • ORGO $6.71
  • Technical
  • Relative Strength Index (RSI)
  • RGR 52.37
  • ORGO 43.72
  • Support Level
  • RGR $39.10
  • ORGO $4.80
  • Resistance Level
  • RGR $40.14
  • ORGO $5.57
  • Average True Range (ATR)
  • RGR 0.59
  • ORGO 0.32
  • MACD
  • RGR -0.18
  • ORGO -0.15
  • Stochastic Oscillator
  • RGR 18.64
  • ORGO 3.73

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: